Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ABL-001 by Compass Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
ABL-001 is under clinical development by Compass Therapeutics and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
Data Insights
ABL-001 by Compass Therapeutics for Metastatic Biliary Tract Cancer: Likelihood of Approval
ABL-001 is under clinical development by Compass Therapeutics and currently in Phase III for Metastatic Biliary Tract Cancer. According to...